ENIGMA Brain Morphometry in CHR-P —Risk Enrichment and Antipsychotics

To the Editor The study of the ENIGMA Clinical High Risk for Psychosis Working Group adopted a case-control design to address a crucial question in the field, ie, whether brain morphometric changes are associated with the severity of positive symptoms or subsequent transition to a psychotic disorder.

Source: JAMA Psychiatry - February 14, 2024 Category: Psychiatry Source Type: research